China SXT Pharmaceuticals Announces 1-for-100 Reverse Stock Split
China SXT Pharmaceuticals, Inc. announced it will implement a 1-for-100 reverse stock split of its Class A ordinary shares, effective October 26, 2026.
Stocks · News reference
China SXT Pharmaceuticals Inc. Announces Termination of Additional Purchase Right
China SXT Pharmaceuticals, Inc. has terminated the right of purchasers to acquire up to an additional $12 million in shares or pre-funded warrants from its October 8, 2026, registered direct offering.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
China SXT Pharmaceuticals Announces Termination Of $12M Additional Purchase Right In Registered Direct Offering
Dow Gains Over 200 Points; GE Aerospace Posts Upbeat Earnings
U.S. stocks mixed: Dow rose 0.43%, while Nasdaq and S&P 500 fell. GE raised its forecast; oil gained and gold declined.